• Home
  • A first-in-human phase I imaging study using hyperpolarized 1 c-13 pyruvate (h-Py) in patients (pts) with localized prostate cancer (l-PCa).

A first-in-human phase I imaging study using hyperpolarized 1 c-13 pyruvate (h-Py) in patients (pts) with localized prostate cancer (l-PCa).

Author List
Andrea Lynne Harzstark, Vivian K. Weinberg, Krystyna Grycz, Ralph E. Hurd, Jan Henrik Ardenkjaer-Larsen, Jonathan Murray, Albert Chen, Marcus Ferrone, Ilwoo Park, Galen Reed, Pamela N. Munster, Eric Jay Small, Lucas E. Carvajal, Mark E. VanCriekinge, Peder E. Larson, Jose Chang, Robert A. Bok, Sarah J. Nelson, Daniel B. Vigneron, John V. Kurhanewicz
Publication
Journal of Clinical Oncology
Publication ID (Profile URL)
https://researcherprofiles.org/profile/117442408
Publication Year
2012
Publication Title
Andrea Lynne Harzstark, Vivian K. Weinberg, Krystyna Grycz, Ralph E. Hurd, Jan Henrik Ardenkjaer-Larsen, Jonathan Murray, Albert Chen, Marcus Ferrone, Ilwoo Park, Galen Reed, Pamela N. Munster, Eric Jay Small, Lucas E. Carvajal, Mark E. VanCriekinge, Peder E. Larson, Jose Chang, Robert A. Bok, Sarah J. Nelson, Daniel B. Vigneron, John V. Kurhanewicz. A first-in-human phase I imaging study using hyperpolarized 1 c-13 pyruvate (h-Py) in patients (pts) with localized prostate cancer (l-PCa). Journal of Clinical Oncology. 2012 May 20; 30(15_suppl):4660-4660.